Follow-up After Metastasectomy in Patients With Kidney Cancer

Running, not enrolling · Phase 2

Conditions studied: Renal Cell Carcinoma

In brief

This phase II trial studies the follow-up after metastasectomy in patients with kidney cancer. Following up patients' health condition after metastasectomy may help doctors to learn if the surgical removal of the primary tumor or the parts of the cancer that has spread to other parts of the body is a good method for treating patients who have kidney cancer.

Key facts

Study ID

NCT00918775

Run by

M.D. Anderson Cancer Center

People needed

86

Starts

2009-06-09

Expected to finish

2026-12-20

Last updated by the study team

2026-04-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with histologically or cytologically confirmed renal cell carcinoma (RCC)
• Patients have clinical reasons for undergoing a surgical resection of tumor; there are two main categories of patients:
• Patients with fully resectable disease as defined by lesions accessible by a surgeon during no more than two separate surgical sessions, and are expected to be rendered surgically no evidence of disease (NED)
• Patients undergoing a noncurative procedure for relief of symptoms or for management of threatening lesions
• Patients have been deemed resectable by the subspecialty surgeon involved in the patient's care
• Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy; the only approved consent is attached to this protocol
• Patients must have ability to comply with study and/or follow-up procedures
• Members of all races and ethnic groups are eligible for this trial

You may not qualify if…

• Patients must not have active acute infections that could be worsened by surgery or interfere with this study
• Patients must not have clinically significant cardiovascular disease, or peripheral vascular disease that creates an unacceptably high operative risk
• Patients must not have history of other diseases, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates surgical resection, or render the subject at high risk from treatment complications
• Patients must not have a history of uncontrolled severe depression

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.